Mitchell A. Sullivan

2.4k total citations
65 papers, 1.7k citations indexed

About

Mitchell A. Sullivan is a scholar working on Rheumatology, Surgery and Molecular Biology. According to data from OpenAlex, Mitchell A. Sullivan has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Rheumatology, 26 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Mitchell A. Sullivan's work include Glycogen Storage Diseases and Myoclonus (29 papers), Pancreatic function and diabetes (23 papers) and Metabolism, Diabetes, and Cancer (10 papers). Mitchell A. Sullivan is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (29 papers), Pancreatic function and diabetes (23 papers) and Metabolism, Diabetes, and Cancer (10 papers). Mitchell A. Sullivan collaborates with scholars based in Australia, China and Canada. Mitchell A. Sullivan's co-authors include Robert G. Gilbert, Bin Deng, Josephine M. Forbes, David Stapleton, Xinle Tan, Francisco Vilaplana, Benjamin L. Schulz, Yu Zhang, Kaiping Wang and Peng Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and PLoS ONE.

In The Last Decade

Mitchell A. Sullivan

64 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell A. Sullivan Australia 28 590 560 374 253 229 65 1.7k
Beatriz Bermúdez Spain 25 538 0.9× 203 0.4× 307 0.8× 454 1.8× 95 0.4× 75 2.0k
Kathy K. W. Au-Yeung Hong Kong 25 915 1.6× 263 0.5× 168 0.4× 117 0.5× 107 0.5× 41 1.9k
Je‐Tae Woo Japan 32 1.7k 2.9× 128 0.2× 204 0.5× 190 0.8× 85 0.4× 81 2.9k
Ramesh Pothuraju India 24 780 1.3× 118 0.2× 123 0.3× 295 1.2× 91 0.4× 54 1.6k
Riku Korhonen Finland 25 869 1.5× 123 0.2× 153 0.4× 360 1.4× 93 0.4× 43 2.2k
Shagufta Moin India 19 505 0.9× 437 0.8× 64 0.2× 117 0.5× 77 0.3× 49 1.8k
Ying Nie China 30 1.2k 2.0× 93 0.2× 270 0.7× 241 1.0× 176 0.8× 91 2.6k
Eeva Moilanen Finland 16 552 0.9× 202 0.4× 117 0.3× 377 1.5× 86 0.4× 30 1.7k
Hiroyuki Yamanaka Japan 28 975 1.7× 104 0.2× 281 0.8× 113 0.4× 116 0.5× 101 2.2k
Jianxin Lü China 20 500 0.8× 125 0.2× 87 0.2× 194 0.8× 66 0.3× 56 1.6k

Countries citing papers authored by Mitchell A. Sullivan

Since Specialization
Citations

This map shows the geographic impact of Mitchell A. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Sullivan more than expected).

Fields of papers citing papers by Mitchell A. Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell A. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Sullivan. The network helps show where Mitchell A. Sullivan may publish in the future.

Co-authorship network of co-authors of Mitchell A. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell A. Sullivan. A scholar is included among the top collaborators of Mitchell A. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell A. Sullivan. Mitchell A. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griffin, Alison, et al.. (2024). Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetes. Journal of Diabetes and its Complications. 38(11). 108870–108870. 1 indexed citations
2.
Tan, Xinle, Ziyi Wang, Qinghua Liu, et al.. (2024). Liver glycogen fragility in the presence of hydrogen-bond breakers. International Journal of Biological Macromolecules. 268(Pt 1). 131741–131741. 3 indexed citations
4.
Stewart, Adam G., Sanmarié Schlebusch, Jamie McMahon, et al.. (2023). First case of mpox diagnosed in Queensland, Australia: clinical and molecular aspects. The Medical Journal of Australia. 218(4). 157–159. 1 indexed citations
5.
Wan, Yujun, Lewis Adler, Marta Navarro, et al.. (2023). Comparing different techniques for obtaining molecular size distributions of glycogen. European Polymer Journal. 201. 112518–112518. 3 indexed citations
6.
Zhang, Qilin, Xiaocui Liu, Mitchell A. Sullivan, Chen Shi, & Bin Deng. (2021). Protective Effect of Yi Shen Pai Du Formula against Diabetic Kidney Injury via Inhibition of Oxidative Stress, Inflammation, and Epithelial‐to‐Mesenchymal Transition in db/db Mice. Oxidative Medicine and Cellular Longevity. 2021(1). 7958021–7958021. 19 indexed citations
7.
Wan, Yujun, Xiaojuan Xu, Robert G. Gilbert, & Mitchell A. Sullivan. (2021). A Review on the Structure and Anti-Diabetic (Type 2) Functions of β-Glucans. Foods. 11(1). 57–57. 14 indexed citations
8.
Wang, Ziyi, Qinghua Liu, Liang Wang, Robert G. Gilbert, & Mitchell A. Sullivan. (2021). Optimization of liver glycogen extraction when considering the fine molecular structure. Carbohydrate Polymers. 261. 117887–117887. 9 indexed citations
9.
Nawaz, Asad, Peng Zhang, Enpeng Li, Robert G. Gilbert, & Mitchell A. Sullivan. (2020). The importance of glycogen molecular structure for blood glucose control. iScience. 24(1). 101953–101953. 17 indexed citations
10.
Shi, Chen, Tingting Wu, Jin-Ping Li, et al.. (2020). Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydrate Polymers. 254. 117232–117232. 39 indexed citations
11.
Wang, Ziyi, Qinghua Liu, Liang Wang, et al.. (2019). Some molecular structural features of glycogen in the kidneys of diabetic rats. Carbohydrate Polymers. 229. 115526–115526. 7 indexed citations
12.
Tan, Xinle, et al.. (2018). Proteomic Investigation of the Binding Agent between Liver Glycogen β Particles. ACS Omega. 3(4). 3640–3645. 38 indexed citations
13.
Deng, Bin, Xinle Tan, Hua Gan, et al.. (2018). Diurnal changes of glycogen molecular structure in healthy and diabetic mice. Carbohydrate Polymers. 185. 145–152. 40 indexed citations
14.
Zhang, Peng, et al.. (2018). Exploring glycogen biosynthesis through Monte Carlo simulation. International Journal of Biological Macromolecules. 116. 264–271. 28 indexed citations
15.
Cao, Peng, Mitchell A. Sullivan, Hanxiang Wang, et al.. (2018). Angelica sinensis polysaccharide protects against acetaminophen-induced acute liver injury and cell death by suppressing oxidative stress and hepatic apoptosis in vivo and in vitro. International Journal of Biological Macromolecules. 111. 1133–1139. 119 indexed citations
16.
Zhuang, Aowen, Felicia Y. T. Yap, Clinton R. Bruce, et al.. (2017). Increased liver AGEs induce hepatic injury mediated through an OST48 pathway. Scientific Reports. 7(1). 12292–12292. 22 indexed citations
17.
Testoni, Giorgia, Jordi Durán, Mar Garcı́a-Rocha, et al.. (2017). Lack of Glycogenin Causes Glycogen Accumulation and Muscle Function Impairment. Cell Metabolism. 26(1). 256–266.e4. 67 indexed citations
18.
Tan, Xinle, Mitchell A. Sullivan, Fei Gao, et al.. (2016). A new non-degradative method to purify glycogen. Carbohydrate Polymers. 147. 165–170. 15 indexed citations
19.
Gilbert, Robert G. & Mitchell A. Sullivan. (2014). The Molecular Size Distribution of Glycogen and its Relevance to Diabetes. Australian Journal of Chemistry. 67(4). 538–543. 13 indexed citations
20.
Sullivan, Mitchell A., et al.. (2013). Extraction, isolation and characterisation of phytoglycogen from su-1 maize leaves and grain. Carbohydrate Polymers. 101. 423–431. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026